Indapamide/Nebivolol Hydrochloride
吲达帕胺/盐酸奈必洛尔
Report date: 2022/01/14 13:23:58
Base Information
Drug NameIndapamide/Nebivolol Hydrochloride
Drug Alias Name +[6]
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes IndapamideNebivolol Hydrochloride
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesZydus Lifesciences Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesZydus Lifesciences Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A